When we first launched the 21st Century Cures initiative in April, we had a pretty good idea that learning about the benefits and risks of a drug or device doesn't end when FDA initially approves or clears the product for use in certain patients with a specific disease or set of conditions.
Upton discusses the ongoing evaluation of drug and device benefits post-approval.
Share
More from Fred Upton
I don`t think we have had so as many folks in that sort of wing of the party elected as we had before, but I think they`re very popular back at home.
Well, he's on the tap lift, the short five, I guess you could call it. I don't think the things that he said back in 2016, maybe 2017 really matter much. He's a MAGA Republican.
This is -- I think, that call -- I think he might have been from South Carolina.
Other voices in this conversation
